Sentinel Trust’s Nautilus Biotechnolgy NAUT Stock Holding History

Sentinel Trust’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Hold	750,000	–	–	0.12%	69
2026 Q1	$2.91M	Hold	750,000	–	–	0.29%	38
2025 Q4	$1.46M	Buy	+750,000	New	+$1.23M	0.14%	64
2025 Q3	–	Sell	-280,000	Closed	-$203K	–	132
2025 Q2	$203K	Hold	280,000	–	–	0.02%	123
2025 Q1	$241K	Buy	280,000 +25,000	+10%	+$37.2K	0.03%	120
2024 Q4	$428K	Sell	255,000 -60,000	-19%	-$144K	0.05%	94
2024 Q3	$898K	Hold	315,000	–	–	0.1%	84
2024 Q2	$737K	Buy	315,000 +5,000	+2%	+$13.1K	0.09%	88
2024 Q1	$911K	Buy	310,000 +10,000	+3%	+$28.4K	0.12%	86
2023 Q4	$897K	Hold	300,000	–	–	0.12%	81
2023 Q3	$948K	Buy	300,000 +20,000	+7%	+$65.1K	0.13%	79
2023 Q2	$1.08M	Buy	280,000 +125,000	+81%	+$360K	0.15%	74
2023 Q1	$429K	Sell	155,000 -30,000	-16%	-$62.9K	0.06%	103
2022 Q4	$333K	Sell	185,000 -30,000	-14%	-$57.9K	0.05%	88
2022 Q3	$456K	Hold	215,000	–	–	0.08%	80
2022 Q2	$578K	Buy	215,000 +130,000	+153%	+$484K	0.09%	80
2022 Q1	$369K	Buy	+85,000	New	+$349K	0.04%	101

Other funds holding NAUT

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PCM

Presidio Capital Management San Diego, California $400M AUM 22.73% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Sentinel Trust's NAUT Position: Q2 2026 in Review

Sentinel Trust held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 750,000 shares worth $1.4M. The position accounts for 0.12% of the portfolio, ranked #69.

Sentinel Trust first reported a position in NAUT in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.91M in Q1 2026. 4 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Sentinel Trust held 750,000 shares of Nautilus Biotechnolgy worth $1.4M as of Q2 2026.
Sentinel Trust left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
Nautilus Biotechnolgy made up 0.12% of Sentinel Trust's portfolio in Q2 2026, its #69 holding.
Sentinel Trust first reported a position in Nautilus Biotechnolgy in Q1 2022 and has held it in 17 quarters since.
Sentinel Trust's Nautilus Biotechnolgy position peaked at $2.91M in Q1 2026.
4 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Sentinel Trust's 13F filing for Q2 2026, filed 13 Jul 2026.